Stay updated on Nivolumab With BRAF/MEK Inhibitors in Melanoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab With BRAF/MEK Inhibitors in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab With BRAF/MEK Inhibitors in Melanoma Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The study record now shows a “TypeError: Failed to fetch” message instead of a 403 error, and the NIH transition notice is no longer displayed.
    Difference
    1%
    Check dated 2026-11-09T13:43:40.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The site footer revision changed from v3.7.2 to v3.8.0 while the page continued to display a 403 error.
    Difference
    0.2%
    Check dated 2026-11-02T13:58:55.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    A banner announces an NIH-wide transition in terminology from “Artificial Intelligence” to “Super Intelligence.” It appears above the unavailable study record.
    Difference
    1%
    Check dated 2026-10-26T14:59:02.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The footer revision number changed from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-19T14:43:52.000Z thumbnail image
  6. Check
    36 days ago
    Change Detected
    Summary
    The site footer revision changed from v3.7.0 to v3.7.1; the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-12T15:50:37.000Z thumbnail image
  7. Check
    57 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error with standard site chrome, indicating the study record at this URL is currently inaccessible.
    Difference
    21%
    Check dated 2026-09-21T22:17:07.000Z thumbnail image

Stay in the know with updates to Nivolumab With BRAF/MEK Inhibitors in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab With BRAF/MEK Inhibitors in Melanoma Clinical Trial page.